Solution for infusion
Manufacturer usually replies in 18 days
A pharmaceutical manufacturer based in the EU that is active in 60+ countries selling its products in Europe, Africa, Middle East, and Asia for 50+ years.
Main therapeutic areas include cardiovascular, anti-infectives, and skin disorders.
The main dosage forms are semi-solid and liquid forms. They are produced in GMP-compliant manufacture.
Regularity team prepares EU CTD format document.
Solution for injection/infusion
(HES 130/0,4) %6
Manufacturer usually replies in 6 days
The company integrates and applies enormous experience and technology in the field of hospital products. Their goal is to become a global leader in intensive care units and maintain that position. The company's headquarters were established in Europe in 1980ies, and serum production was continuing in a plant in Europe till the end of the 2000s. With a nationwide market share of 50%, it has become one of the leading serum producers. They've already started making the first ready-to-use injections.
Manufacturer usually replies in 12 days
The company was founded in the 1930s. They manufacture medicines and biomedical materials of the highest quality with scientifically proven efficacy and safety, designed to help save the lives of patients. They even are a manufacturer of parenteral solutions, blood transfusion bags, special small-volume injectables, and disposable medical products for critical care of critically ill patients, and their market directly to health institutions.
Already have an account? Sign in here